BSE Live
Oct 28, 16:01Prev. Close
904.95
Open Price
904.95
Bid Price (Qty.)
905.00 (3)
Offer Price (Qty.)
909.50 (113)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Profit & Loss account of Kwality Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 370.20 | 307.08 | 250.99 | 456.13 | 261.50 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 370.20 | 307.08 | 250.99 | 456.13 | 261.50 | |
| Total Operating Revenues | 370.20 | 307.17 | 250.99 | 456.13 | 261.50 | |
| Other Income | 1.92 | 1.83 | 2.94 | 3.51 | 1.59 | |
| Total Revenue | 372.12 | 309.00 | 253.94 | 459.64 | 263.09 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 165.41 | 153.81 | 113.22 | 199.31 | 165.28 | |
| Purchase Of Stock-In Trade | 15.90 | 0.85 | 0.04 | 3.80 | 0.22 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 1.17 | -1.48 | -3.20 | -2.51 | 0.09 | |
| Employee Benefit Expenses | 43.76 | 32.53 | 29.90 | 20.09 | 15.68 | |
| Finance Costs | 9.88 | 10.39 | 6.02 | 2.92 | 2.61 | |
| Depreciation And Amortisation Expenses | 18.26 | 19.51 | 14.92 | 10.64 | 6.44 | |
| Other Expenses | 63.51 | 54.83 | 50.74 | 63.72 | 50.97 | |
| Total Expenses | 317.89 | 270.44 | 211.65 | 297.97 | 241.29 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 54.23 | 38.57 | 42.29 | 161.67 | 21.80 | |
| Exceptional Items | 0.00 | -7.10 | -16.53 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 54.23 | 31.47 | 25.76 | 161.67 | 21.80 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 14.69 | 7.92 | 6.48 | 41.00 | 5.80 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | -1.59 | -0.44 | 0.14 | 0.27 | 0.16 | |
| Tax For Earlier Years | 1.23 | 0.00 | -0.33 | 0.35 | 0.42 | |
| Total Tax Expenses | 14.34 | 7.48 | 6.29 | 41.63 | 6.38 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 | |
| Profit/Loss From Continuing Operations | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 | |
| Profit/Loss For The Period | 39.89 | 23.98 | 19.47 | 120.05 | 15.42 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 38.44 | 23.11 | 18.45 | 115.70 | 14.86 | |
| Diluted EPS (Rs.) | 38.44 | 23.11 | 18.45 | 115.70 | 14.86 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 65.11 | 29.41 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 134.20 | 135.87 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 3.00 | 0.00 | 0.00 |
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y
08.09.2025
Kwality Pharmac Standalone June 2025 Net Sales at Rs 111.48 crore, up 39.21% Y-o-Y
20.05.2025
Kwality Pharmac Consolidated March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
20.05.2025
Kwality Pharmac Standalone March 2025 Net Sales at Rs 115.68 crore, up 25.77% Y-o-Y
01.02.2025
Kwality Pharmac Consolidated December 2024 Net Sales at Rs 84.41 crore, up 8.08% Y-o-Y